Combining Smac mimetic Birinapant with caspase-8 inhibitor Emricasan can promote necroptosis in myeloid leukemia cells, which may emerge as a promising therapeutic method of AML (Brumatti et al., 2016). Here, CASP8 is linked to acute myeloid leukemia.